Saturday 17 October 2026
Export ELUT’s income statement to Excel — free account
Elutia Inc.
ELUT Healthcare Medical Devices
In the quarter to June 2026, revenue fell 11.7%, EPS grew 26.1% and free cash flow fell 2.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.79
0.00
0.00%
Follow ELUT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Piotroski F-Score |
5 | 2 | 2 | 2 | 3 | 4 | — | — | — |
P/S ratio |
2.32 | 7.52 | 1.83 | 2.34 | 1.39 | 3.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(4.10) | (10.90) | (7.45) | (3.53) | (1.50) | (0.53) | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(8.05) | (29.13) | (20.18) | (9.27) | (5.05) | (1.30) | (5.96) | (4.07) | — |
P/Operating CF |
(1.15) | (8.87) | (5.00) | (10.63) | (10.30) | (23.85) | (7.65) | (7.65) | — |
Beneish M-Score |
0.81 | (5.01) | (5.22) | (0.07) | (3.15) | (3.08) | (3.18) | — | — |
P/B ratio |
1.03 | 0.00 | 0.00 | 0.00 | 4.87 | 6.15 | 0.00 | 0.00 | — |
Price to Tangible BV |
1.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
1.49 | 8.25 | 2.01 | 3.18 | 1.14 | 2.64 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.41) | (5.27) | (2.29) | (3.54) | (3.49) | (8.26) | (7.50) | (7.50) | — |
EV/FCF |
(0.39) | (5.12) | (2.25) | (3.45) | (3.40) | (7.89) | (7.00) | (7.00) | — |
Quick Ratio |
2.03 | 0.54 | 0.59 | 0.81 | 1.40 | 1.74 | 0.54 | 0.72 | — |
Current Ratio |
2.22 | 0.69 | 0.73 | 1.19 | 1.82 | 2.23 | 1.01 | 1.36 | — |
Net Debt/EBITDA |
1.51 | (0.39) | (0.17) | (0.64) | 0.62 | 1.60 | (4.24) | (3.63) | — |
Debt/Assets |
0.00% | 66.03% | 54.52% | 53.87% | 27.50% | 29.13% | 47.58% | 37.32% | 0.00% |
Debt/Equity |
0.00 | (0.52) | (0.61) | (7.37) | 1.37 | 1.16 | (0.39) | (0.41) | — |
Asset Turnover |
0.25 | 0.36 | 0.44 | 0.35 | 0.63 | 0.67 | 0.93 | 1.64 | — |
Operating CF/Net income |
(0.84) | 0.42 | 0.58 | 0.65 | 0.62 | 0.54 | 0.61 | 0.47 | — |
Capex/Depreciation |
(0.67) | (0.19) | (0.09) | (0.14) | (0.10) | (0.16) | (0.14) | (0.05) | — |
Interest Coverage |
69.54 | (32.88) | (5.27) | (6.88) | (4.33) | (2.41) | (1.56) | (1.49) | — |
| (574.35%) | 127.15% | 172.60% | (775.14%) | (144.57%) | 147.81% | 24.24% | 23.48% | — | |
| 108.41% | (135.63%) | (67.08%) | (48.37%) | (33.11%) | (39.72%) | (25.81%) | (48.45%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | (146.02%) | (921.57%) | (156.82%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
160.83% | 492.59% | 324.29% | (394.97%) | (109.74%) | (74.32%) | (1,029.22%) | (204.35%) | — |
Average Days of Receivables |
432.90 | 177.52 | 87.90 | 269.16 | 46.18 | 61.28 | 61.50 | 67.32 | — |
Research and Development Expense of Revenue |
33.86% | 20.72% | 17.78% | 32.40% | 19.55% | 13.95% | 5.59% | 6.36% | — |
Selling, General and Administrative Expense of Revenue |
169.57% | 159.40% | 109.88% | 142.15% | 68.61% | 66.08% | 60.08% | 55.55% | — |
Intangible Assets out of Total Assets |
0.02 | 0.07 | 0.27 | 0.22 | 0.27 | 0.26 | 0.56 | 0.60 | 0.00 |
Share Based Compensation of Revenue |
42.41% | 54.54% | 9.85% | 15.29% | 7.46% | 1.83% | 0.48% | 0.68% | — |
Graham Net Nets |
0.74 | (0.52) | (1.12) | (0.42) | (0.09) | (0.02) | 2.36 | 2.36 | — |
Graham Number |
4.32 | 8.69 | 10.07 | 4.43 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
179.71% | (56.42%) | (84.80%) | (59.55%) | (37.46%) | (230.28%) | (6.62%) | (6.62%) | — |
Free Cash Flow Yield |
(163.36%) | (21.44%) | (48.69%) | (39.42%) | (24.03%) | (11.14%) | (176.40%) | (176.40%) | — |
Revenue per Share |
0.30 | 0.50 | 1.36 | 1.72 | 4.54 | 14.96 | 66.41 | 62.01 | — |
Operating CF per Share |
(1.08) | (0.78) | (1.20) | (1.55) | (1.48) | (4.78) | (11.18) | (8.65) | — |
Capex per Share |
(0.05) | (0.02) | (0.02) | (0.04) | (0.04) | (0.22) | (0.89) | (0.30) | — |
Free Cash Flow per Share |
(1.13) | (0.80) | (1.22) | (1.59) | (1.51) | (5.00) | (12.08) | (8.95) | — |
Cash per Share |
0.88 | 0.46 | 1.06 | 1.23 | 2.91 | 13.86 | 4.01 | 3.83 | — |
Shareholders Equity per Share |
0.67 | (1.59) | (2.13) | (0.36) | 1.29 | 7.30 | (85.31) | (68.95) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.67 | (1.59) | (2.13) | (0.36) | 1.29 | 7.30 | (85.31) | (68.95) | — |
Free Cash Flow |
(46.69) | (23.31) | (22.11) | (21.97) | (15.81) | (14.27) | (7.80) | (5.64) | — |
Working Capital |
30.68 | (11.62) | (11.78) | 8.08 | 21.43 | 32.93 | 0.17 | 4.79 | — |
Capital Expenditures |
(1.88) | (0.65) | (0.35) | (0.54) | (0.37) | (0.64) | (0.58) | (0.19) | — |
Net Current Asset Value |
21.14 | (56.21) | (50.77) | (23.17) | (6.22) | (2.27) | (81.44) | (73.01) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.15 | 0.05 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.11 | 5.14 | 23.05 | 15.71 | 3.21 | 3.43 | 4.05 | 4.57 | — |
Cash ROIC |
(72.92%) | 254.26% | (507.86%) | (44.81%) | (25.34%) | (16.89%) | 24.99% | 24.32% | — |
Accounts Receivable Turnover |
1.14 | 2.23 | 2.10 | 2.02 | 7.20 | 5.93 | 5.95 | 5.41 | — |
Accounts Payable Turnover |
1.27 | 2.11 | 6.00 | 8.26 | 15.60 | 9.73 | 11.34 | 11.32 | — |
Inventory Turnover |
2.51 | 2.68 | 3.38 | 1.77 | 2.88 | 2.56 | 3.16 | 3.15 | — |
Average Days of Payables |
306.95 | 195.35 | 85.07 | 41.07 | 20.36 | 33.89 | 39.32 | 25.12 | — |
Days of Inventory on Hand |
167.67 | 90.92 | 102.71 | 126.75 | 122.93 | 166.93 | 113.45 | 117.89 | — |
Average Receivables |
10.81 | 6.50 | 11.77 | 11.79 | 6.58 | 7.20 | 7.21 | 7.21 | — |
Average Payables |
4.47 | 3.67 | 2.28 | 1.48 | 1.82 | 2.27 | 2.04 | 2.04 | — |
Average Inventory |
2.27 | 2.89 | 4.05 | 6.90 | 9.84 | 8.65 | 7.32 | 7.32 | — |
Average Assets |
49.24 | 39.78 | 56.13 | 68.01 | 74.99 | 63.79 | 46.26 | 23.87 | — |
Average Common Equity |
(9.29) | (42.43) | (21.82) | 4.24 | 17.18 | (17.14) | (49.26) | (49.26) | — |
Columns are period end dates